The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
JNK signaling in cancer cell survival
Abstract
c‐Jun N‐terminal kinase (JNK) is involved in cancer cell apoptosis; however, emerging evidence indicates that this Janus signaling promotes cancer cell survival. JNK acts synergistically with NF‐κB, JAK/STAT, and other signaling molecules to exert a survival function. JNK positively regulates autophagy to counteract apoptosis, and its effect on autophagy is related to the development of chemotherapeutic resistance. The prosurvival effect of JNK may involve an immune evasion mechanism mediated by transforming growth factor‐β, toll‐like receptors, interferon‐γ, and autophagy, as well as compensatory JNK‐dependent cell proliferation. The present review focuses on recent advances in understanding the prosurvival function of JNK and its role in tumor development and chemoresistance, including a comprehensive analysis of the molecular mechanisms underlying JNK‐mediated cancer cell survival. There is a focus on the specific “Yin and Yang” functions of JNK1 and JNK2 in the regulation of cancer cell survival. We highlight recent advances in our knowledge of the roles of JNK in cancer cell survival, which may provide insight into the distinct functions of JNK in cancer and its potential for cancer therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The JAK/STAT pathway interacts with the RAS/MAPK and NF-κB signaling pathways, forming a complex network of cross-talk that influences various cellular processes, including cell proliferation, survival, and apoptosis.”
From Multiple myeloma: signaling pathways and targeted therapy (2024) · cites this paper as [118]
In the citing paper
“However, the JAK/STAT pathway, through its downstream effector Zfh2, can control the expression of the fos gene and the pro-apoptotic hid gene, thereby promoting cell survival mediated by JNK and inhibiting JNK-induced cell apoptosis [118].”
From Multiple myeloma: signaling pathways and targeted therapy (2024) · cites this paper as [118]
Citations
Cites
3 retracted
Sui, X., Kong, N., Wang, X., Fang, Y., Hu, X., Xu, Y., Chen, W., Wang, K., Li, D., Jin, W., et al. (2014) · Scientific Reports · doi:10.1038/srep04694 · Cited by 96
Self-citationRetractedVarı́, R., Scazzocchio, B., Santangelo, C., Filesi, C., Galvano, F., D’Archivio, M., Masella, R., & Giovannini, C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/351827 · Cited by 41
RetractedMihailidou, C., Papakotoulas, P., Papavassiliou, A. G., & Karamouzis, M. V. (2017) · Oncotarget · doi:10.18632/oncotarget.23164 · Cited by 31
RetractedPatterns of somatic mutation in human cancer genomes
Greenman, C. D., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G. R., Davies, H. R., Teague, J. W., Butler, A. P., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,143
Signal integration by JNK and p38 MAPK pathways in cancer development
Wagner, E. F., & Nebreda, Á. R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2694 · Cited by 2,635
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Autophagy Is Activated for Cell Survival after Endoplasmic ReticulumStress
Ogata, M., Hino, S.-I., Saito, A., Morikawa, K., Kondo, S., Kanemoto, S., Murakami, T., Taniguchi, M., Tanii, I., Yoshinaga, K., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01453-06 · Cited by 1,832
Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway
Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., & Davis, R. J. (2000) · Science · doi:10.1126/science.288.5467.870 · Cited by 1,728
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
Thomas, D. A., & Massagué, J. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.012 · Cited by 1,355
JNK1-Mediated Phosphorylation of Bcl-2 Regulates Starvation-Induced Autophagy
Wei, Y., Pattingre, S., Sinha, S., Bassik, M., & Levine, B. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.06.001 · Cited by 1,329
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Kortylewski, M., Kujawski, M., Wang, T., Sheng, W., Zhang, S., Pilon‐Thomas, S., Niu, G., Kay, H. D., Mulé, J. J., Kerr, W. G., et al. (2005) · Nature Medicine · doi:10.1038/nm1325 · Cited by 1,026
Ryoo, H. D., Gorenc, T., & Steller, H. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.08.019 · Cited by 624
JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships
Zeke, A., Misheva, M., Reményi, A., & Bogoyevitch, M. A. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00043-14 · Cited by 552
Targeting the RAF–MEK–ERK pathway in cancer therapy
Montagut, C. O., & Settleman, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.022 · Cited by 466
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
Hemann, M. T., Bric, A., Teruya‐Feldstein, J., Herbst, A., Nilsson, J. A., Cordon‐Cardo, C., Cleveland, J. L., Tansey, W. P., & Lowe, S. W. (2005) · Nature · doi:10.1038/nature03845 · Cited by 452
MAPK/JNK signalling: a potential autophagy regulation pathway
Zhou, Y.-Y., Li, Y., Jiang, W.-Q., & Zhou, L.-F. (2015) · Bioscience Reports · doi:10.1042/bsr20140141 · Cited by 444
JNK at the crossroad of obesity, insulin resistance, and cell stress response
Solinas, G., & Becattini, B. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.12.001 · Cited by 444
Activation of the JNK signaling pathway: Breaking the brake on apoptosis
Lin, A. (2002) · BioEssays · doi:10.1002/bies.10204 · Cited by 432
Dual Role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation
Wei, Y., Sinha, S. C., & Levine, B. (2008) · Autophagy · doi:10.4161/auto.6788 · Cited by 424
Distinct Roles for JNK1 and JNK2 in Regulating JNK Activity and c-Jun-Dependent Cell Proliferation
Sabapathy, K., Hochedlinger, K., Nam, S. Y., Bauer, A., Karin, M., & Wagner, E. F. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.028 · Cited by 397
JNK-signaling: A multiplexing hub in programmed cell death
Dhanasekaran, D. N., & Reddy, E. P. (2017) · Genes & Cancer · doi:10.18632/genesandcancer.155 · Cited by 369
Almeida, E. A. C., Ilić, D., Han, Q., Hauck, C. R., Jin, F., Kawakatsu, H., Schlaepfer, D. D., & Damsky, C. H. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.3.741 · Cited by 358
JNK signalling in cancer: in need of new, smarter therapeutic targets
Bubici, C., & Papa, S. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12432 · Cited by 355
Chemical Genetic Analysis of the Time Course of Signal Transduction by JNK
Ventura, J., Hübner, A., Zhang, C., Flavell, R. A., Shokat, K. M., & Davis, R. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.018 · Cited by 329
Jia, G., Cheng, G., Gangahar, D. M., & Agrawal, D. K. (2006) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2006.01454.x · Cited by 306
The functional contrariety of JNK
Bode, A. M., & Dong, Z. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20348 · Cited by 304
Gauron, C., Rampon, C., Bouzaffour, M., Ipendey, E., Teillon, J., Volovitch, M., & Vriz, S. (2013) · Scientific Reports · doi:10.1038/srep02084 · Cited by 296
Role of JNK1-dependent Bcl-2 Phosphorylation in Ceramide-induced Macroautophagy
Pattingre, S., Bauvy, C., Carpentier, S., Levade, T., Levine, B., & Codogno, P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805920200 · Cited by 290
Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis
Inokuchi, S., Aoyama, T., Miura, K., Österreicher, C. H., Kodama, Y., Miyai, K. N., Akira, S., Brenner, D. A., & Seki, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909781107 · Cited by 283
Linking JNK signaling to NF-κB: a key to survival
Papa, S., Zazzeroni, F., Pham, C. G., Bubici, C., & Franzoso, G. (2004) · Journal of Cell Science · doi:10.1242/jcs.01483 · Cited by 277
JunD Mediates Survival Signaling by the JNK Signal Transduction Pathway
Lamb, J. A., Ventura, J., Hess, P., Flavell, R. A., & Davis, R. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00203-x · Cited by 261
The Role of Apoptosis-Induced Proliferation for Regeneration and CancerPreprint
Ryoo, H. D., & Bergmann, A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008797 · Cited by 243
Cisplatin induces a persistent activation of JNK that is related to cell death
Sánchez‐Pérez, I., Murguía, J. R., & Perona, R. (1998) · Oncogene · doi:10.1038/sj.onc.1201578 · Cited by 236
Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy
Abdollahi, A., & Folkman, J. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2009.12.001 · Cited by 236
Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance†
Singh, R., Wang, Y., Xiang, Y., Tanaka, K. E., Gaarde, W. A., & Czaja, M. J. (2008) · Hepatology · doi:10.1002/hep.22578 · Cited by 228
The JNK Signaling Pathway in Renal Fibrosis
Grynberg, K., Ma, F. Y., & Nikolic‐Paterson, D. J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00829 · Cited by 226
Sun, G., & Irvine, K. D. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2010.11.036 · Cited by 219
JNK-Induced Apoptosis, Compensatory Growth, and Cancer Stem Cells
Chen, F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1982 · Cited by 205
Liu, J., Minemoto, Y., & Lin, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10844-10856.2004 · Cited by 201
JNK Pathway Signaling: A Novel and Smarter Therapeutic Target for Various Biological Diseases
Kumar, A., Singh, U. K., Kini, S. G., Garg, V., Agrawal, S., Tomar, P. K., Pathak, P., Chaudhary, A., Gupta, P., & Malik, A. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.132 · Cited by 200
Tumor Evasion from T Cell Surveillance
Töpfer, K., Kempe, S., Müller, N., Schmitz, M., Bachmann, M. P., Cartellieri, M., Schackert, G., & Temme, A. (2011) · BioMed Research International · doi:10.1155/2011/918471 · Cited by 178
Yorkie: the final destination of Hippo signaling
Oh, H., & Irvine, K. D. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.04.005 · Cited by 169
Hayakawa, J., Depatie, C., Ohmichi, M., & Mercola, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210992200 · Cited by 158
c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells
Gururajan, M., Chui, R., Karuppannan, A. K., Ke, J., JENNINGS, C. D., & Bondada, S. (2005) · Blood · doi:10.1182/blood-2004-10-3819 · Cited by 156
Tang, F., Tang, G., Xiang, J., Dai, Q., Rosner, M. R., & Lin, A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8571-8579.2002 · Cited by 145
c-Jun NH2-Terminal Kinase (JNK)1 and JNK2 Have Distinct Roles in CD8+ T Cell Activation
Conze, D. B., Krahl, T., Kennedy, N. J., Weiss, L., Lumsden, J. M., Hess, P., Flavell, R. A., Gros, G. S. L., Davis, R. J., & Rincón, M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011508 · Cited by 145
The true face of JNK activation in apoptosis
Lin, A., & Dibling, B. C. (2002) · Aging Cell · doi:10.1046/j.1474-9728.2002.00014.x · Cited by 144
Ganapathy‐Kanniappan, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.04.002 · Cited by 144
Wang, X., Liu, Q., Ihsan, A., Huang, L., Dai, M., Hao, H., Cheng, G., Liu, Z., Wang, Y., & Yuan, Z. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs106 · Cited by 131
Self-citationJNK/c-Jun Signaling Mediates an Anti-Apoptotic Effect of RANKL in Osteoclasts
Ikeda, F., Matsubara, T., Tsurukai, T., Hata, K., Nishimura, R., & Yoneda, T. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080211 · Cited by 130
Vucur, M., Reisinger, F., Gautheron, J., Janssen, J., Roderburg, C., Cardenas, D. V., Kreggenwinkel, K., Koppe, C., Hammerich, L., Hakem, R., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.035 · Cited by 127
Almasi, S., Kennedy, B. E., Elaghil, M., Sterea, A. M., Gujar, S. A., Partida‐Sánchez, S., & Hiani, Y. E. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.817635 · Cited by 126
Yang, J., & Yao, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025744 · Cited by 118
The JNK Are Important for Development and Survival of Macrophages
Himes, S. R., Sester, D. P., Ravasi, T., Cronau, S. L., Sasmono, T., & Hume, D. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2219 · Cited by 117
Trichothecenes: immunomodulatory effects, mechanisms, and anti-cancer potential
Wu, Q., Wang, X., Nepovimová, E., Miron, A., Liu, Q., Wang, Y., Su, D., Yang, H., Li, L., & Kuča, K. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2118-3 · Cited by 115
Self-citationComerford, K. M., Cummins, E. P., & Taylor, C. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1919 · Cited by 108
Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis
Hochedlinger, K., Wagner, E. F., & Sabapathy, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205348 · Cited by 105
Lee, Y. S., Kim, S.-Y., Hong, H. K., Hong, H. K., Lee, Y., Oh, B. Y., Lee, W. Y., & Cho, Y. B. (2016) · Oncotarget · doi:10.18632/oncotarget.9209 · Cited by 105
A Wingless and Notch double‐repression mechanism regulates G1–S transition in the Drosophila wing
Herranz, H., Pérez, L., Martín, F. A., & Milán, M. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.84 · Cited by 105
Feng, X., Liu, H., Zhang, Z., Gu, Y., Qiu, H., & He, Z. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0594-1 · Cited by 100
Suzuki, S., Okada, M., Shibuya, K., Seino, M., Satō, A., Takeda, H., Seino, S., Yoshioka, T., & Kitanaka, C. (2014) · Oncotarget · doi:10.18632/oncotarget.2693 · Cited by 94
Liu, G.-Y., Jiang, X., Zhu, X., He, W., Kuang, Y., Ren, K., Lin, Y., & Gou, X. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.101 · Cited by 93
Autophagy stimulation as a promising approach in treatment of neurodegenerative diseases
Pierzynowska, K., Gaffke, L., Cyske, Z., Puchalski, M., Rintz, E., Bartkowski, M., Osiadły, M., Pierzynowski, M., Mantej, J., Piotrowska, E., et al. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0214-6 · Cited by 93
JNK2: A Negative Regulator of Cellular Proliferation
Sabapathy, K., & Wagner, E. F. (2004) · Cell Cycle · doi:10.4161/cc.3.12.1315 · Cited by 91
Balance between NF-κB and JNK/AP-1 activity controls dendritic cell life and death
Kriehuber, E., Bauer, W. M., Charbonnier, A.-S., Winter, D., Amatschek, S., Tamandl, D., Schweifer, N., Stingl, G., & Maurer, D. (2005) · Blood · doi:10.1182/blood-2004-08-3072 · Cited by 90
JAK/STAT signalling mediates cell survival in response to tissue stress
Fortezza, M. L., Schenk, M., Cosolo, A., Kolybaba, A. M., Grass, I., & Classen, A.-K. (2016) · Development · doi:10.1242/dev.132340 · Cited by 89
Role of JNK signaling in oral cancer: A mini review
Gkouveris, I., & Nikitakis, N. G. (2017) · Tumor Biology · doi:10.1177/1010428317711659 · Cited by 87
Zhou, H., Shen, T., Shang, C., Luo, Y., Liu, L., Yan, J., Li, Y., & Huang, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2471 · Cited by 86
Arbour, N., Naniche, D., Homann, D., Davis, R. J., Flavell, R. A., & Oldstone, M. B. A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011481 · Cited by 83
Song, W., Ma, Y., Wang, J., Brantley‐Sieders, D. M., & Chen, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2136 · Cited by 82
Ma, J., Zhang, L., Han, W., Shen, T., Ma, C., Liu, Y., Nie, X., Liu, M., Ran, Y., & Zhu, D. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m024398 · Cited by 77
Yin, H., Yang, X., Gu, W., Liu, Y., Li, X., Huang, X., Zhu, X., Tao, Y., Gou, X., & He, W. (2017) · Oncotarget · doi:10.18632/oncotarget.17796 · Cited by 74
Antioxidant agents against trichothecenes: new hints for oxidative stress treatment
Wu, Q., Wang, X., Nepovimová, E., Wang, Y., Yang, H., Li, L., Zhang, X., & Kuča, K. (2017) · Oncotarget · doi:10.18632/oncotarget.22800 · Cited by 73
Self-citationPoulton, J. S., Cuningham, J. C., & Peifer, M. A. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.08.007 · Cited by 72
Tafolla, E., Wang, S., Wong, B., Leong, J., & Kapila, Y. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500331200 · Cited by 72
Kim, J.-H., Lee, S. C., Ro, J., Kang, H. S., Kim, H. S., & Yoon, S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.008 · Cited by 71
A role for JNK/SAPK in proliferation, but not apoptosis, of IL-3-dependent cells
Smith, A., Ramos‐Morales, F., Ashworth, A., & Collins, M. K. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00380-0 · Cited by 71
Warner, S. J., Yashiro, H., & Longmore, G. D. (2010) · Current Biology · doi:10.1016/j.cub.2010.03.025 · Cited by 70
Schmid, C. A., Robinson, M. D., Scheifinger, N. A., Müller, S., Cogliatti, S., Tzankov, A., & Mueller, A. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20141957 · Cited by 64
Apoptosis and Compensatory Proliferation Signaling Are Coupled by CrkI-Containing Microvesicles
Gupta, K. H., Goldufsky, J. W., Wood, S. J., Tardi, N. J., Moorthy, G. S., Gilbert, D. Z., Zayas, J. P., Hahm, E., Altintas, M. M., Reiser, J., et al. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.05.014 · Cited by 62
Kim, Y., Kang, K. S., Choi, K., & Ko, H. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.04.054 · Cited by 60
IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance
YE, X.-L., Zhao, Y., Weng, G., Chen, Y., Wei, X., Shao, J., & Ji, H. (2015) · Oncology Reports · doi:10.3892/or.2015.3898 · Cited by 60
Zhu, M., Tong, J. L., Xu, Q., Nie, F., Xi Tao, X. U., Shu Dong, X. I. A. O., & Ran, Z. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041763 · Cited by 59
Chen, H.-L., Chiang, P.-C., Lo, C.-H., Lo, Y., Hsu, D. K., Chen, H., & Liu, F. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.366 · Cited by 58
Pro-survival effects of JNK and p38 MAPK pathways in LPS-induced activation of BV-2 cells
Svensson, C., Part, K., Künnis-Beres, K., Kaldmäe, M., Fernaeus, S. Z., & Land, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.083 · Cited by 56
Granato, M., Santarelli, R., Lotti, L. V., Renzo, L. D., Gonnella, R., Garufi, A., Trivedi, P., Frati, L., D’Orazi, G., Faggioni, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075965 · Cited by 55
Zindl, C. L., & Chaplin, D. (2010) · Science · doi:10.1126/science.1190310 · Cited by 55
Yang, X., Chen, G.-L., Yu, S., Xu, C. S., Xin, Y.-H., Li, T., Shi, Y., Ai, G., Duan, J., Qian, C., et al. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.12.002 · Cited by 53
Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines
Haga, Y., Kanda, T., Nakamura, M., Nakamoto, S., Sasaki, R., Takahashi, K., Wu, S., & Yokosuka, O. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174153 · Cited by 52
Zhong, S., Longo, J. F., & Johnson, D. L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01365-06 · Cited by 50
Lin, X., Fang, Q., Chen, S., Zhe, N., Chai, Q., Yu, M., Zhang, Y., Wang, Z., & Wang, J. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.02.009 · Cited by 47
Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development
Wang, J., & Tai, G. (2016) · Targeted Oncology · doi:10.1007/s11523-016-0446-5 · Cited by 46
Shinoda, C., Maruyama, M., 藤下, 隆., Dohkan, J., Oda, H., Shinoda, K., Yamada, T., Miyabayashi, K., Hayashi, R., Kawagishi, Y., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21094 · Cited by 46
Jun Kinase Delays Caspase-9 Activation by Interaction with the Apoptosome
Tran, T., Andreka, P. G., Rodrigues, C. O., Webster, K. A., & Bishopric, N. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702210200 · Cited by 45
Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1
Roh, Y.-G., Mun, M.-H., Jeong, M.-S., Kim, W., Lee, S.-R., Chung, J.-W., Kim, S. I., Kim, T. N., Nam, J. K., & Leem, S. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.2.222 · Cited by 45
Goswami, K. K., Barik, S., Sarkar, M., Bhowmick, A. K., Biswas, J. K., Bose, A., & Baral, R. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.01.015 · Cited by 44
Zhong, Y., Naito, Y., Cope, L., Naranjo‐Suarez, S., Saunders, T., Hong, S., Goggins, M., Herman, J. M., Wolfgang, C. L., & Iacobuzio–Donahue, C. A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2823 · Cited by 44
TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathway
Wang, S., Gao, K., Deng, D., Cai, J., Xiao, Z., He, L., Jiao, H., Ye, Y., Yang, R., Li, T., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6694 · Cited by 44
Dong, Y., Lu, C.-W., Zhang, L., Yang, J. Y., Hameed, W., & Chen, W. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.10.015 · Cited by 43
Crosstalk of JNK1-STAT3 is critical for RAW264.7 cell survival
Wu, Q., Wang, X., Wan, D., Li, J., & Yuan, Z. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.09.013 · Cited by 43
Self-citationCrosstalk between JNK and NF-κB signaling pathways via HSP27 phosphorylation in HepG2 cells
Ruan, J., Qi, Z., Shen, L., Jiang, Y., Xu, Y., Lan, L., Luo, L., & Yin, Z. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.11.045 · Cited by 42
JNK1 Inhibition Attenuates Hypoxia-Induced Autophagy and Sensitizes to Chemotherapy
Vasilevskaya, I. A., Selvakumaran, M., Roberts, D., & O'Dwyer, P. J. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0035 · Cited by 41
Yu, P., Zhang, C., Gao, C., Ma, T., Zhang, H., Zhou, M., Yang, Y.-W., Yang, L., & Kong, L. (2017) · Oncotarget · doi:10.18632/oncotarget.19299 · Cited by 38
mTORC1 pathway mediates beta cell compensatory proliferation in 60 % partial-pancreatectomy mice
Li, W., Zhang, H., Nie, A., Ni, Q., Li, F., Ning, G., Li, X., Gu, Y., & Wang, Q. (2016) · Endocrine · doi:10.1007/s12020-016-0861-5 · Cited by 37
Activation of JNK by TPA promotes apoptosis via PKC pathway in gastric cancer cells
Chen, Y. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i6.1014 · Cited by 37
Shen, S., Zhou, M., Huang, K., Wu, Y., Ma, Y., Wang, J., Ma, J., & Fan, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.441 · Cited by 35
cJun N-terminal kinase (JNK) mediates cortico-striatal signaling in a model of Parkinson's disease
Spigolon, G., Cavaccini, A., Trusel, M., Tonini, R., & Fisone, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.10.015 · Cited by 34
Basal Cancer Cell Survival Involves JNK2 Suppression of a Novel JNK1/c-Jun/Bcl-3 Apoptotic Network
Ahmed, S. U., & Milner, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007305 · Cited by 34
Liu, J., Guo, F., Wu, H., Wang, Y., & Liu, J.-S. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6031 · Cited by 34
von Koschembahr, A., Swope, V. B., Starner, R. J., & ABDEL‐MALEK, Z. A. (2015) · Experimental Dermatology · doi:10.1111/exd.12638 · Cited by 33
Sun, Y., Wang, R., Qiao, M., Yan-chun, X., Guan, W., & Wang, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26433 · Cited by 32
Role of mitogen-activated protein kinase signaling in the pathogenesis of dengue virus infection
Sreekanth, G. P., Yenchitsomanus, P., & Limjindaporn, T. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.05.002 · Cited by 32
Tumour growth and immune evasion as targets for a new strategy in advanced cancer
Nicolini, A., Ferrari, P., Rossi, G., & Carpi, A. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0142 · Cited by 32
Kim, J.-H., Kim, T. H., Kang, H. S., Ro, J., Kim, H. S., & Yoon, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.036 · Cited by 32
Yue, W., Clark, J. J., Fernando, A., Domann, F. E., & Hansen, M. R. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor068 · Cited by 31
Zhu, X., Zhou, M., Guanyu, L., Huang, X., He, W., Gou, X., & Jiang, T. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4287 · Cited by 31
Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death
Gancz, D., Donin, N., & Fishelson, Z. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.09.016 · Cited by 29
Mao, C.-P., Wu, T. ‐., Song, K., & Kim, T. W. (2014) · OncoImmunology · doi:10.4161/21624011.2014.947871 · Cited by 27
Oppositional Regulation of Noxa by JNK1 and JNK2 during Apoptosis Induced by Proteasomal Inhibitors
Pietkiewicz, S., Sohn, D., Piekorz, R. P., Grether‐Beck, S., Budach, W., Sabapathy, K., & Jänicke, R. U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061438 · Cited by 25
Autophagy-independent function of Atg1 for apoptosis-induced compensatory proliferation
Li, M., Lindblad, J. L., Perez, E., Bergmann, A., & Fan, Y. (2016) · BMC Biology · doi:10.1186/s12915-016-0293-y · Cited by 25
Huang, X., Zhang, H., Yang, X., Dong, X., Xie, X. S., Yin, H., Gou, X., Lin, Y., & He, W. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000499 · Cited by 24
Foxo1 Attenuates NaF-Induced Apoptosis of LS8 Cells through the JNK and Mitochondrial Pathways
Li, J., Zhao, L., Zhao, X., Wang, P., Liu, Y., & Ruan, J. (2017) · Biological Trace Element Research · doi:10.1007/s12011-017-1015-1 · Cited by 24
Autophagy blockade sensitizes the anticancer activity of CA-4 via JNK-Bcl-2 pathway
Li, Y., Luo, P., Wang, J., Dai, J., Yang, X., Wu, H., Yang, B., & He, Q. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.11.018 · Cited by 23
Peng, B., Chai, Y., Li, Y., Liu, X., & Zhang, J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1899-0 · Cited by 23
Ashenden, M., van Weverwijk, A., Murugaesu, N., Fearns, A., Campbell, J., Gao, Q., Iravani, M., & Isacke, C. M. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0731 · Cited by 23
Synthesis and SAR of novel isoxazoles as potent c-jun N-terminal kinase (JNK) inhibitors
He, Y., Duckett, D. R., Chen, W., Ling, Y. Y., Cameron, M. D., Li, L., Ruiz, C. H., LoGrasso, P. V., Kamenecka, T. M., & Koenig, M. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.11.052 · Cited by 22
Signalling pathways involved in clinical responses to chemotherapy
Perona, R., & Sánchez‐Pérez, I. (2007) · Clinical & Translational Oncology · doi:10.1007/s12094-007-0115-3 · Cited by 22
Suissa, Y., Oren, Z., Dinur, T., Arama, E., & Gerlitz, O. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193235 · Cited by 21
TAK1–JNK Axis Mediates Survival Signal through Mcl1 Stabilization in Activated T Cells
Hirata, Y., Sugie, A., Matsuda, A., Matsuda, S., & Koyasu, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202809 · Cited by 21
STAT3-enhancing germline mutations contribute to tumor-extrinsic immune evasion
Kogan, D., Grabner, A., Yanucil, C., Faul, C., & Ulaganathan, V. K. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96708 · Cited by 21
Ahmed-de-Prado, S., Díaz-García, S., & Baonza, A. (2018) · Developmental Biology · doi:10.1016/j.ydbio.2018.05.021 · Cited by 21
The c-Jun N-terminal kinase inhibitor SP600125 inhibits human cytomegalovirus replication
Zhang, H., Niu, X., Qian, Z., Qian, J., & Xuan, B. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24286 · Cited by 21
JNK activation is required for TNFα-induced apoptosis in human hepatocarcinoma cells
Minero, V. G., Khadjavi, A., Costelli, P., Baccino, F. M., & Bonelli, G. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.05.017 · Cited by 20
Inhibition of JNK and prothymosin-alpha sensitizes hepatocellular carcinoma cells to cisplatin
Lin, Y.-T., Liu, Y., & Chao, C. C. ‐. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.10.003 · Cited by 20
Attenuated JNK signaling in multidrug-resistant leukemic cells. Dual role of MAPK in cell survival
Cerezo, D., Ruiz‐Alcaraz, A. J., Lencina, M., Cánovas, M., García–Peñarrubia, P., Martínez-López, I., & Martín‐Orozco, E. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.12.003 · Cited by 19
Meguro, M., Nishimura, F., Ohyama, H., Takashiba, S., Murayama, Y., & Matsushita, S. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00123-6 · Cited by 19
TGF‐β Down‐regulates Apolipoprotein M Expression through the TAK‐1‐JNK‐c‐Jun Pathway in HepG2 Cells
Ren, K., Mo, Z., Liu, X., Tang, Z., Jiang, Y., Peng, X., Zhang, Q., Shi, J., & Yi, G. (2016) · Lipids · doi:10.1007/s11745-016-4227-9 · Cited by 18
Cardoso, B. A., Belo, H., Barata, J. T., & Almeida, A. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143897 · Cited by 17
Clavier, A., Rincheval‐Arnold, A., Baillet, A., Mignotte, B., & Guénal, I. (2016) · Cell Cycle · doi:10.1080/15384101.2015.1100776 · Cited by 16
Liang, Y., Jiao, J., Liang, L., Zhang, J., Lu, Y. J., Xie, H., Liang, Q., Wan, D., Duan, L., Wu, Y., et al. (2018) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12709 · Cited by 16
Deng, H., Zhang, J., Yoon, T., Song, D., Li, D.-D., & Lin, A. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.11.011 · Cited by 15
Fiocchetti, M., Cipolletti, M., & Marino, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189179 · Cited by 15
Tripathi, D., Cheekatla, S. S., Paidipally, P., Radhakrishnan, R. K., Welch, E., Thandi, R. S., Tvinnereim, A., & Vankayalapati, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-21477-9 · Cited by 15
A Tumor Cell-Intrinsic Yin-Yang Determining Immune Evasion
Horton, B. L., & Spranger, S. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.001 · Cited by 14
Imai, J. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0241 · Cited by 12
Zhou, Y., Wang, Y., Zhao, Z., Wang, Y., Zhang, N., Zhang, H., & Liu, L. (2017) · Tumor Biology · doi:10.1177/1010428317701655 · Cited by 8
Cited by
Sorted by citations
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
Wu, Q., Li, Y., Nepovimová, E., Heger, Z., Wu, W., Kuča, K., & Adam, V. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01292-6 · Cited by 518
Self-citationHypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis
Fuhrmann, D. C., Mondorf, A. W., Beifuß, J., Jung, M., & Brüne, B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101670 · Cited by 415
The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer
Hammouda, M., Ford, A. E., Liu, Y., & Zhang, J. Y. (2020) · Cells · doi:10.3390/cells9040857 · Cited by 296
Selective inhibitors for JNK signalling: a potential targeted therapy in cancer
Wu, Q., Wu, W., Jacevic, V. M., França, T. C. C., Wang, X., & Kuča, K. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1720013 · Cited by 172
Self-citation
Metadata
- Authors
- Wu, Q., Wu, W., Fu, B., Shi, L., Wang, X., & Kuca, K.
- Affiliations
- Nanjing Agricultural University (CN)
- Harvard University (US)
- University of Manchester (GB)
- Huazhong Agricultural University (CN)
- Department of Chemistry Faculty of Science, University of Hradec Kralove Hradec Kralove Czech Republic
- Corresponding author
- Wang, Xu
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2019-03-25
- Volume
- 39
- Issue
- 6
- Pages
- 2082-2104
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2923315793
- Cited by
- 322
- References
- 146
- Citations by year
- 2026: 22 · 2025: 51 · 2024: 68 · 2023: 42 · 2022: 56 · 2021: 43 · 2020: 29 · 2019: 11
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medicinal Research Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (31572575, 31602114)
- China Postdoctoral Science Foundation (2016T90477)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- JNK signaling, c-Jun N-terminal kinase, tumor cell survival, apoptosis, NF-κB, JAK/STAT signaling, autophagy, chemoresistance, immune evasion, TGF-beta, Toll-like receptors, interferon-gamma, JNK1, JNK2, carcinogenesis, cell proliferation
- MeSH terms
- Animals, Autophagy, Cell Survival, Humans, Neoplasms, Drug Resistance, Neoplasm, MAP Kinase Signaling System, JNK Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review